Rarecan eyes up to £3m investment this year as cancer platform targets rapidly growing market

1 Mar

Written By Alexandra Collingbourne

Alexandra Collingbourne

Antiverse Raises Funding and Demonstrates Therapeutic Antibody Identification With AI-driven Drug Discovery Platform

Five Alarm Bio raises £500k to strengthen Cambridge’s anti-ageing hand